Appropriate Dose Selection - How to Optimize Clinical Drug Development

J. Venitz (u. a.)

ISBN 10: 3540278672 ISBN 13: 9783540278672
Editore: Springer, 2006
Nuovi Buch

Da preigu, Osnabrück, Germania Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Venditore AbeBooks dal 5 agosto 2024

Questo articolo specifico non è più disponibile.

Riguardo questo articolo

Descrizione:

Appropriate Dose Selection - How to Optimize Clinical Drug Development | J. Venitz (u. a.) | Buch | xvi | Englisch | 2006 | Springer | EAN 9783540278672 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Codice articolo 102292161

Segnala questo articolo

Riassunto:

Optimal dose individualization has become more important in improving clinical efficacy and safety. This is due in part to the variability in drug response. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. This book reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agents.

Contenuti: Extrapolation of Preclinical Data into Clinical Reality ― Translational Science.- Smarter Candidate Selection ― Utilizing Microdosing in Exploratory Clinical Studies.- The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes.- Using Exposure ― Response and Biomarkers to Streamline Early Drug Development.- Experiences with Dose Finding in Patients in Early Drug Development: The Use of Biomarkers in Early Decision Making.- Genotype and Phenotype Relationship in Drug Metabolism.- Clinical Trials in Elderly Patients.- Dose Finding in Pediatric Patients.- Integration of Pediatric Aspects into the General Drug Development Process.- Current Stumbling Blocks in Oncology Drug Development.- Exploratory IND: A New Regulatory Strategy for Early Clinical Drug Development in the United States.- Ethnic Aspects of Cancer Trials in Asia.- Evaluation of the Effect on Cardiac Repolarization (QTc Interval) of Oncologic Drugs.- The Role of PET Scanning in Determining Pharmacoselective Doses in Oncology Drug Development.- Biometrical Aspects of Drug Development.- Preventing Postmarketing Changes in Recommended Doses and Marketing Withdrawals.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Titolo: Appropriate Dose Selection - How to Optimize...
Casa editrice: Springer
Data di pubblicazione: 2006
Legatura: Buch
Condizione: Neu

I migliori risultati di ricerca su AbeBooks